About
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Adzenys XR-ODT, indicated for the treatment of ADHD in patients 6 years of age and older, is the first approved product using the CompanyÍs extended-release (XR)-orally disintegrating tablet (ODT) technology platform. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
- Company Name:Neos Therapeutics, Inc.
(View Trends)
-
Headquarters: (View Map)Grand Prairie, TX, United States
-
Pharmaceuticals
-
200 - 500 employees
Site Traffic
- 5016724 Global Rank
- 1325685 United States
Traffic Sources
-
Search92.58%
-
Direct7.42%
-
Display0.00%
-
Mail0.00%
-
Referrals0.00%
-
Social0.00%
Powered by
![]()
Alexa Traffic Data
Global Rank
1,022,187
80,566
Links In Count
15
8
United States Rank
139,116
52
United States Page Views
16.7%
5.1%
Top Countries
- United States 16.7%
- Chile 11.8%
- India 7.4%
Top Sites Linking In
Top Search Keywords
- Chemistry
- Nuclear Magnetic Resonance
- Commercial Companies
- New Instruments
They are headquartered at Grand Prairie, TX, United States, and have 2 advertising & marketing contacts listed on Kochava. Neos Therapeutics, Inc. works with Advertising technology companies such as DoubleClick.Net.
